Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects

29 januari 2018 uppdaterad av: Sol Fernandez-Gonzalo, Corporacion Parc Tauli

Individuals with schizophrenia have important and persistent deficits in multiple neurocognitive domains as well as in the Social Cognition (SC). SC refers to the mental operations underlying social behavior, and it is understood as a multidimensional construct that comprises emotional processing (EP), social perspective and knowledge, attributional bias and theory of mind (ToM) or mentalizing. Mentalizing and EP skills have been the two most studied subdomains of SC in schizophrenia. Both domains have been found to be impaired in chronic schizophrenia patients as well as in patients in early stages of the illness. In this context, although negative symptoms may play and important role, females seem to perform better than males in ToM and EP tasks, suggesting the presence of gender differences in the SC skills in patients with schizophrenia. However, to our knowledge, there are no studies that have explored the gender-related differences between cognitive and affective ToM and its relationship with the EP performance in schizophrenia patients of recent diagnosis comparing with healthy subjects.

In this line, the main objective of this project is to analyze the influence of gender in the cognitive and affective ToM abilities, in a group of patients with schizophrenia in early stages of the illness comparing with healthy subjects. Secondarily, this study pretends to explore the association between EP skills and affective ToM tasks performance in males and females with and without recent diagnosis of schizophrenia.

Studieöversikt

Detaljerad beskrivning

50 patients (25 men and 25 women) will be recruited to participate in the study. Diagnosis of schizophrenia or schizoaffective disorder will be obtained through the medical records of each patient, and confirmed with the administration of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) (American Psychiatric Association, 1994) by an expert psychiatrist. The same professional will confirm the inclusion and exclusion criteria, and administrate and correct the Positive and Negative Syndrome Scale (PANNS) of all patients. An expert neuropsychologist will administrate and correct the the abbreviated form of the Wechsler Adult Intelligence Scale (WAIS-III) and the ToM and EP tasks.

In a second phase, a total of 50 healthy people (25 men and 25 women), matched according to age and years of schooling with the previous group, will be recruited. An expert neuropsychologist will confirm the inclusion and exclusion criteria, and administrate and correct the Vocabulary subtests of the WAIS-III and ToM and EP tasks.

All of them will be informed about the characteristics of the study before participating, and will sign an informed consent approved by the ethical committee of the hospital. The subjects will participate voluntarily.

4 groups ANOVAs will be performed for studying differences in affective and cognitive ToM between the groups (1-Women With Recent Diagnosis of Schizophrenia; 2-Men With Recent Diagnosis of Schizophrenia; 3-Healthy Women; 4-Healthy Men). Linear regression models will be performed for exploring the relationship between gender, negative symptoms (only in the schizophrenia sample) and EP (independents variables) in affective ToM (dependent variable).

Studietyp

Observationell

Inskrivning (Faktisk)

80

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Barcelona
      • Sabadell, Barcelona, Spanien, 08208
        • Corporació Parc Tauli

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 45 år (Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Females and males with and without schizophrenia of recent diagnosis.

Beskrivning

PARTICIPANTS WITH SCHIZOPHRENIA

Inclusion Criteria:

  • Patients meeting DSM-IV criteria for schizophrenia or schizoaffective disorder with less than 5 years of evolution of the disorder.
  • Being an outpatient for at least 4 weeks before the study (clinical stability).
  • No changes in the antipsychotic medication during the month before the study.
  • Score less than 4 in the P1, P2 and P3 items of the PANSS.
  • Score less than 4 in the Calgary Depression Scale.

Exclusion Criteria:

  • Intellectual disability (IQ<70).
  • History of brain damage.
  • History of substance abuse (except nicotine or caffeine) during the last 12 months before the study.

PARTICIPANTS WITHOUT SCHIZOPHRENIA

Inclusion Criteria:

• Healthy people over 18 years old.

Exclusion Criteria:

  • Sensory impairment: visual or hearing disabilities.
  • Intellectual disability (IQ<70).
  • History of neurologic disease.
  • History of psychiatric disorder.
  • History of substance abuse (except nicotine or caffeine) during the last 12 months before the study.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: Case-Control
  • Tidsperspektiv: Tvärsnitt

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Women schiz.
Women with recent diagnosis of schizophrenia
Men schiz.
Men with recent diagnosis of schizophrenia
Women healthy
Women without diagnosis of schizophrenia or other neurological and/or psychiatric diagnosis
Men healthy
Men without diagnosis of schizophrenia or other neurological and/or psychiatric diagnosis

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Affective Theory of Mind
Tidsram: Through study completion, an average of 6 months
Measured by: Reading the Mind in the Eyes test (RMET)
Through study completion, an average of 6 months
Cognitive Theory of Mind
Tidsram: Through study completion, an average of 6 months
Measured by: False belief stories
Through study completion, an average of 6 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Emotional Processing
Tidsram: Through study completion, an average of 6 months
Measured by: Pictures of Facial Affect (POFA)
Through study completion, an average of 6 months
Psychosis Symptoms
Tidsram: Through study completion, an average of 6 months
Measured by: Positive and Negative Syndrome Scale
Through study completion, an average of 6 months

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Intelligence Quotient (IQ) in schizophrenia groups
Tidsram: Through study completion, an average of 6 months
Measured by: The abbreviated form of the Wechsler Adult Intelligence Scale (WAIS-III) (Blyder et al., 2000)
Through study completion, an average of 6 months
Intelligence Quotient (IQ) in healthy groups
Tidsram: Through study completion, an average of 6 months
Measured by: The Vocabulary subtest (WAIS-III) in healthy participants.
Through study completion, an average of 6 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Sol Fernandez-Gonzalo, PhD, Corporació Parc Tauli

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 september 2015

Primärt slutförande (Faktisk)

1 juli 2016

Avslutad studie (Faktisk)

1 juli 2016

Studieregistreringsdatum

Först inskickad

8 oktober 2015

Först inskickad som uppfyllde QC-kriterierna

13 oktober 2015

Första postat (Uppskatta)

14 oktober 2015

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

31 januari 2018

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

29 januari 2018

Senast verifierad

1 januari 2018

Mer information

Termer relaterade till denna studie

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera